Luther King Capital Management (LKCM)’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,867
Closed -$331K 506
2017
Q1
$331K Buy
+2,867
New +$333K ﹤0.01% 440
2016
Q4
Sell
-3,050
Closed -$343K 504
2016
Q3
$343K Hold
3,050
﹤0.01% 426
2016
Q2
$378K Buy
3,050
+100
+3% +$12.1K ﹤0.01% 427
2016
Q1
$332K Sell
2,950
-41,616
-93% -$4.32M ﹤0.01% 437
2015
Q4
$4.85M Buy
+44,566
New +$5.1M 0.05% 249
2013
Q4
Sell
-4,750
Closed -$804K 534
2013
Q3
$804K Hold
4,750
0.01% 459
2013
Q2
$720K Buy
+4,750
New +$673K 0.01% 473

Other funds holding CLB

Luther King Capital Management (LKCM)'s CLB Position: Q2 2017 in Review

Luther King Capital Management (LKCM) sold out of Core Laboratories (CLB) in Q2 2017, closing a stake of 2,867 shares — an estimated $331K sold.

Luther King Capital Management (LKCM) first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $4.85M in Q4 2015. 360 funds tracked by Wall St. Rank hold CLB as of Q2 2017.

  • Luther King Capital Management (LKCM) reported no remaining Core Laboratories position as of Q2 2017 after selling out during the quarter.
  • Luther King Capital Management (LKCM) sold 2,867 Core Laboratories shares in Q2 2017, an estimated $331K.
  • Luther King Capital Management (LKCM) first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
  • Luther King Capital Management (LKCM)'s Core Laboratories position peaked at $4.85M in Q4 2015.
  • 360 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2017.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2017, filed 10 Aug 2017.